Amplifi Vascular key facts
as of Oct 2026- Developer of endovascular medical devices designed for the treatment of neurovascular and peripheral vascular diseases.
- Amplifi Vascular is valued at approximately $37.0M as of Oct 2026 (last reported valuation).
- It has raised $24.0M; the latest was Early Stage VC ($17.0M) in Jan 2025.
- Notable investors include BioGenerator Ventures.
- Status: Privately Held (backing).
Amplifi Vascular's last reported valuation, Nov 2024. Nothing priced has surfaced since.
- ·Watch Amplifi Vascular: the Monday email on marks, rounds and moves
Amplifi Vascular funding rounds
No funding rounds for Amplifi Vascular are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Amplifi Vascular
1Amplifi Vascular valuation
Amplifi Vascular's last reported valuation was $37 million in Nov 2024. No priced round, secondary trade or fund mark has surfaced since.
Amplifi Vascular investors
1 investor is on record for Amplifi Vascular, including BioGenerator Ventures. By type, the record holds 1 venture capital firm.
About Amplifi Vascular
Developer of endovascular medical devices designed for the treatment of neurovascular and peripheral vascular diseases. The company develops immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter system, enabling healthcare professionals to improve procedural efficiency, reduce complications, and enhance patient outcomes in vascular interventions.
- Sector
- Healthcare
- HQ
- Chesterfield, MO, United States
- Founded
- 2023
- Employees
- 9
- Website
- amplifivascular.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.